Publication alert📣 If you are a clinician looking after individuals on anticoagulation at child bearing age, please make sure HMB is addressed.
A major problem with very little data on its management!
Watch the space for upcoming clinical trials.@ThrombosisRese1@HaemSTAR_UK
If you have a project idea and you want to take it forward #DragonDen session #BSHmeeting25 is the perfect platform to pitch your project and get expert feedback✨
Abstract submission is still open! @HaemSTAR_UK@UK_TReN@BritSocHaem
https://t.co/xCFUiPtiB7
Great news! HaemSTAR's RAPIDO audit of reversal agents for DOACs has been accepted for poster presentation at #ASH2024 and given an abstract achievement award! 🥳 https://t.co/ZFG2Oc6O9H
@richardbuka@HaemSTAR_UK Single biggest safety concern for me is the fact obstetric teams use a different clinical letter system to the rest of the hospital in the 2 Trusts I cover. No one can see each other's plan
🚨🚨 #ANNEXa_I published!! You've been waiting and now it's here!! 🔓 Andexanet for Factor Xa Inhibitor–Associated Acute Intracerebral Hemorrhage | New England Journal of Medicine (https://t.co/86OM9qeNtg)